e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Beyond continuous positive airway pressure treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
A. Bikov (Manchester, United Kingdom), M. Meszaros (Budapest, Hungary), J. Vestbo (Manchester, United Kingdom), A. Mathioudakis (Manchester, United Kingdom), L. Kunos (Budapest, Hungary)
Source:
International Congress 2019 – Beyond continuous positive airway pressure treatment
Session:
Beyond continuous positive airway pressure treatment
Session type:
Thematic Poster
Number:
4175
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bikov (Manchester, United Kingdom), M. Meszaros (Budapest, Hungary), J. Vestbo (Manchester, United Kingdom), A. Mathioudakis (Manchester, United Kingdom), L. Kunos (Budapest, Hungary). The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea. 4175
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
Source: Sleep and Breathing Conference 2021
Year: 2021
Daytime sleepiness in patients with treated obstructive sleep apnea
Source: Eur Respir J 2007; 30: Suppl. 51, 594s
Year: 2007
Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
Diagnosing excessive daytime sleepiness in obstructive sleep apnoea
Source: 5th Sleep and Breathing Conference
Year: 2019
The frequency of REM related OSA among patients with mild OSA and the relation between apnea and daytime sleepiness among these patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Effects of solriamfetol on real-world driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
Source: Sleep and Breathing Conference 2021
Year: 2021
Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
Obesity and daytime somnolence at patients with obstructive sleep apnea and sistemic hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 562s
Year: 2002
Daytime sleepiness and quality of life in patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021
Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms
Source: Eur Respir J 2011; 37: 98-105
Year: 2011
Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
Sleep architecture in patients with moderate to severe sleep apnea without daytime sleepiness
Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation
Year: 2007
Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment
Source: Eur Respir J 2013; 41: 593-600
Year: 2013
Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome
Source: Eur Respir J 2001; 17: 838-847
Year: 2001
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002
Determinants of subjective sleepiness in suspected obstructive sleep apnoea
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
Degree of sleepiness and cardiac alterations in non-hypertensive obstructive sleep apnea (OSA) patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept